| CUV Stock | | | EUR 0.84 0.02 2.33% |
Director
Mrs. Brenda Mary Shanahan, BComm, FAICD, ASIA, is NonExecutive Independent Director of Clinuvel Pharmaceuticals Ltd since July 1, 2010. Mrs Shanahan is an established member of the Australian finance community who has also spent more than two decades working and investing in medical RD and commercialisation. She is currently a nonexecutive director of listed companies Phoslock Water Solutions Ltd and Bell Financial Group, Mrs Shanahan is also a nonexecutive director of DMP Asset Management, a director of the Kimberly Foundation of Australia Ltd, and Chair of the Aikenhead Centre for Medical Discovery in Melbourne. Previously Mrs Shanahan was a member of the Australian Stock Exchange and an executive director of a stockbroking firm, a fund management company and an actuarial company. Until 2017, she was Chair of St Vincents Medical Research Institute and also a nonexecutive director of Challenger Limited . Mrs Shanahan was also formerly Chair of Challenger Listed Investments Ltd, the reporting entity for four ASX listed firms . Mrs Shanahan joined CLINUVEL in 2007, and was NonExecutive Chair of the Board from late 2007 until July 2010. Her depth of experience across global markets and medical research provides significant value to the current Board and Group. since 2010.
| Tenure | 14 years |
| Phone | 852 3959 2888 |
| Web | https://www.realord.com.hk |
Realord Group Management Efficiency
Realord Group's management efficiency ratios could be used to measure how well Realord Group manages its routine affairs as well as how well it operates its assets and liabilities.
Realord Group Holdings has accumulated 11.1
B in total debt with debt to equity ratio
(D/E) of 2.31, implying the company greatly
relies on financing operations through barrowing. Realord Group Holdings has a current ratio of 1.18, suggesting that it
is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Realord Group until it has trouble settling it off, either with new capital or with free cash flow. So, Realord Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Realord Group Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Realord to invest in growth at high rates of return. When we think about Realord Group's use of debt, we should always consider it together with cash and equity.
Similar Executives
Realord Group Holdings Limited, an investment holding company, engages in the commercial printing, hangtag, motor vehicles parts, financial service, trading, property, and environmental protection businesses in the Peoples Republic of China, Hong Kong, Japan, and internationally. Realord Group Holdings Limited is a subsidiary of Manureen Holdings Limited. REALORD GRP operates under Waste Management classification in Germany and is traded on Frankfurt Stock Exchange. It employs 513 people. Realord Group Holdings (CUV) is traded on Frankfurt Exchange in Germany and employs 513 people.
Management Performance
Realord Group Holdings Leadership Team
Elected by the shareholders, the Realord Group's board of directors comprises two types of representatives: Realord Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Realord. The board's role is to monitor Realord Group's management team and ensure that shareholders' interests are well served. Realord Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Realord Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susan Smith, Non-Executive Director | |
| Madam Su, CEO Director | |
| Xiaodong Lin, Ex Director | |
| Willem Blijdorp, Non-Executive Chairman of the Board | |
| Jeffrey Rosenfeld, Non-Executive Director | |
| Philippe Wolgen, Chief Executive Officer, Managing Director, Executive Director | |
| Karen Agersborg, Non-Executive Director | |
| Chin Tsang, CFO Sec | |
| Darren Keamy, Chief Financial Officer, Company Secretary | |
| Xiaohui Lin, Ex Chairman | |
| Dennis Wright, Vice President - Scientific Affairs | |
| Brenda Shanahan, Non-Executive Independent Director | |
Realord Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Realord Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Realord Stock
Realord Group financial ratios help investors to determine whether Realord Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Realord with respect to the benefits of owning Realord Group security.